Free Trial

Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of "Hold" by Brokerages

Teladoc Health logo with Medical background

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been assigned an average rating of "Hold" from the twenty analysts that are covering the stock, MarketBeat reports. Thirteen research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $11.81.

A number of equities research analysts have weighed in on the stock. TD Cowen decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Thursday, October 31st. Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a report on Wednesday, February 12th. Piper Sandler reissued an "overweight" rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Finally, The Goldman Sachs Group upped their price target on Teladoc Health from $14.00 to $16.00 and gave the stock a "buy" rating in a research report on Tuesday.

Get Our Latest Stock Report on TDOC

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the company's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company's stock, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

A number of institutional investors have recently bought and sold shares of TDOC. Versant Capital Management Inc lifted its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC bought a new stake in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC grew its holdings in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. Finally, Sterling Capital Management LLC grew its stake in Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Performance

NYSE TDOC traded down $1.18 during trading hours on Friday, hitting $11.52. The company's stock had a trading volume of 14,240,875 shares, compared to its average volume of 7,945,688. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market cap of $1.98 billion, a P/E ratio of -2.00 and a beta of 1.05. The company's 50 day simple moving average is $10.52 and its two-hundred day simple moving average is $9.41. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $15.95.

Teladoc Health Company Profile

(Get Free Report

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines